These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25097298)

  • 41. Regression-based multiple treatment effect estimation under covariate-adaptive randomization.
    Gu Y; Liu H; Ma W
    Biometrics; 2023 Dec; 79(4):2869-2880. PubMed ID: 37700503
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Two-Stage TMLE to reduce bias and improve efficiency in cluster randomized trials.
    Balzer LB; van der Laan M; Ayieko J; Kamya M; Chamie G; Schwab J; Havlir DV; Petersen ML
    Biostatistics; 2023 Apr; 24(2):502-517. PubMed ID: 34939083
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Estimation and testing in targeted goup sequential covariate-adjusted randomized clinical trials.
    Chambaz A; van der Laan MJ
    Scand Stat Theory Appl; 2014 Mar; 41(1):104-140. PubMed ID: 30100663
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A note on semiparametric efficient generalization of causal effects from randomized trials to target populations.
    Li F; Hong H; Stuart EA
    Commun Stat Theory Methods; 2023; 52(16):5767-5798. PubMed ID: 37484707
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Causal inference with interfering units for cluster and population level treatment allocation programs.
    Papadogeorgou G; Mealli F; Zigler CM
    Biometrics; 2019 Sep; 75(3):778-787. PubMed ID: 30859545
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Defining and estimating effects in cluster randomized trials: A methods comparison.
    Benitez A; Petersen ML; van der Laan MJ; Santos N; Butrick E; Walker D; Ghosh R; Otieno P; Waiswa P; Balzer LB
    Stat Med; 2023 Aug; 42(19):3443-3466. PubMed ID: 37308115
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Finite-sample corrected generalized estimating equation of population average treatment effects in stepped wedge cluster randomized trials.
    Scott JM; deCamp A; Juraska M; Fay MP; Gilbert PB
    Stat Methods Med Res; 2017 Apr; 26(2):583-597. PubMed ID: 25267551
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Estimation with interval censored data and covariates.
    Van der Laan MJ; Hubbard A
    Lifetime Data Anal; 1997; 3(1):77-91. PubMed ID: 9384627
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Estimators for the value of the optimal dynamic treatment rule with application to criminal justice interventions.
    Montoya LM; van der Laan MJ; Skeem JL; Petersen ML
    Int J Biostat; 2023 May; 19(1):239-259. PubMed ID: 35659857
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estimation of time-specific intervention effects on continuously distributed time-to-event outcomes by targeted maximum likelihood estimation.
    Rytgaard HCW; Eriksson F; van der Laan MJ
    Biometrics; 2023 Dec; 79(4):3038-3049. PubMed ID: 36988158
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Asymptotic theory and inference of predictive mean matching imputation using a superpopulation model framework.
    Yang S; Kim JK
    Scand Stat Theory Appl; 2020 Sep; 47(3):839-861. PubMed ID: 34305262
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Statistical inferences for data from studies conducted with an aggregated multivariate outcome-dependent sample design.
    Lu TS; Longnecker MP; Zhou H
    Stat Med; 2017 Mar; 36(6):985-997. PubMed ID: 27966260
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adaptive design: estimation and inference with censored data in a semiparametric model.
    Shen Y; Cheng Y
    Biostatistics; 2007 Apr; 8(2):306-22. PubMed ID: 16787996
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Statistical inference for response adaptive randomization procedures with adjusted optimal allocation proportions.
    Zhu H
    J Biopharm Stat; 2017; 27(5):732-740. PubMed ID: 27937121
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Propensity score matching in randomized clinical trials.
    Xu Z; Kalbfleisch JD
    Biometrics; 2010 Sep; 66(3):813-23. PubMed ID: 19995353
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regression analysis for covariate-adaptive randomization: A robust and efficient inference perspective.
    Ma W; Tu F; Liu H
    Stat Med; 2022 Dec; 41(29):5645-5661. PubMed ID: 36134688
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect Estimation in Point-Exposure Studies with Binary Outcomes and High-Dimensional Covariate Data - A Comparison of Targeted Maximum Likelihood Estimation and Inverse Probability of Treatment Weighting.
    Pang M; Schuster T; Filion KB; Schnitzer ME; Eberg M; Platt RW
    Int J Biostat; 2016 Nov; 12(2):. PubMed ID: 27889705
    [TBL] [Abstract][Full Text] [Related]  

  • 59. On adaptive propensity score truncation in causal inference.
    Ju C; Schwab J; van der Laan MJ
    Stat Methods Med Res; 2019 Jun; 28(6):1741-1760. PubMed ID: 29991330
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A semiparametric method for evaluating causal effects in the presence of error-prone covariates.
    Liu J; Li W
    Biom J; 2021 Aug; 63(6):1202-1222. PubMed ID: 34357652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.